Bisphosphonates are analogues of inorganic pyrophosphate and are inhibitors
of bone resorption. Many derivatives have been developed for the treatment
of enhanced bone resorption; several reports reveal that treatment with bi
sphosphonates is able to reduce the pain associated with different painful
diseases. This study tested the antinociceptive action of four bisphosphona
tes, clodronate, alendronate, pamidronate and etidronate, in comparison wit
h that of morphine and acetylsalicylic acid using two algesimetric tests in
mice, tail-flick and writhing tests. In the tail-flick test, after intrave
nous (i.v.) injection, a dose-dependent antinociception was present after p
amidronate, clodronate and acetylsalicylic acid whereas etidronate and alen
dronate produced an analgesic effect only with the highest dose tested. We
also studied the central effect of clodronate and pamidronate and, after in
tracerebroventricular injection, both bisphosphonates showed a dose-depende
nt antinociceptive effect. In the writhing test clodronate and pamidronate
showed a statistically significant antinociceptive action after i.v. and in
tramuscular administration. To verify if clodronate and pamidronate could m
odulate the peripheral opioid receptors we evaluated the gastrointestinal t
ransit time in mice, but we did not find any effect on the gastrointestinal
motility. These data indicate that clodronate and pamidronate present a ce
ntral and peripheral antinociceptive effect: however, the main mechanism ca
nnot be determined from the present data. We discuss the possible pharmacol
ogical hypothesis to interpret the present results. The findings suggest a
pharmacological role of the bisphosphonates in the modulation of antinocice
ption even in acute conditions not related to accelerated osteolytic and in
flammatory response, with a possible clinical application to control pain.
(C) 2001 International Association for the Study of Pain. Published by Else
vier Science B.V. All rights reserved.